#United States #New York #The Gross Law Firm #Inc. #Securities Fraud #DexCom

Important Announcement for DexCom, Inc. Shareholders

DexCom, Inc. (NASDAQ: DXCM) is currently facing a class action lawsuit concerning allegations of securities fraud. As per a recent announcement by The Gross Law Firm, shareholders who acquired shares between July 26, 2024, and September 17, 2025, are specifically invited to discuss their rights and options regarding this case.

Background of the Case

The lawsuit centers around claims that DexCom misled its investors through false statements and omissions of critical information. The allegations assert that DexCom had indeed made unauthorized design changes to its glucose monitoring devices, notably the G6 and G7 models, without the necessary approval from the U.S. Food and Drug Administration (FDA). These changes purportedly compromised the reliability and safety of these products, putting users' health at risk.

The complaint outlines various key points that shareholders should be aware of:

1. Unauthorized Design Changes: DexCom is accused of implementing material modifications to the G6 and G7 devices without FDA approval, thereby raising serious questions about the reliability of the products.
2. Health Risks: The changes reportedly rendered these products less dependable, which presents a significant risk for users relying on accurate glucose readings.
3. Overstated Claims: Shareholders argue that the company's communications exaggerated the device enhancements, compromising their understanding of the actual product reliability and functionality.
4. Regulatory Scrutiny: The lawsuit further claims that these actions placed DexCom at risk of increased regulatory scrutiny, legal repercussions, and substantial reputational damage.

Key Dates and Actions for Shareholders

Shareholders affected by this situation are strongly encouraged to take prompt action. The deadline to register interests in joining the class action is December 26, 2025. By registering, shareholders will not only be informed about the developments in the case but will also have the opportunity to elect a lead plaintiff, although this is not mandatory to partake in any recovery.

To register, shareholders must provide details of their purchases during the specified timeframe. Once registered, they will have access to a monitoring service that will keep them updated on the status of the class action proceedings.

Why Choose The Gross Law Firm?

The Gross Law Firm prides itself on protecting the rights of investors affected by deceitful practices in the corporate landscape. They are a nationally recognized class action firm dedicated to ensuring companies operate under fair business practices and are held accountable for misleading their shareholders. The firm encourages all investors negatively impacted by deceptive practices to consider participating in this class action as a path towards potential recovery.

Shareholders interested in this lawsuit should reach out to The Gross Law Firm at their contact information provided below, ensuring they do not miss out on this crucial opportunity to advocate for their rights and recover losses.

Contact Information

• - Firm Name: The Gross Law Firm
• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

This class action lawsuit serves as a vital reminder that investors must remain vigilant and informed about the companies in which they invest, especially concerning disclosures and operational integrity.